Skip to main content
. 2024 Feb 13;14:1336619. doi: 10.3389/fcimb.2024.1336619

Table 4.

Univariate and multivariate logistic regression analysis for risk factors of HBV reactivation.

Univariate Multivariate
OR(95%CI) P value OR(95%CI) P value
Age (≥50 years) 0.419 (0.146-1.199) 0.105
Sex(male) 0.663 (0.083-5.314) 0.699
History of alcoholism (yes) 0.839 (0.26-2.713) 0.77
Antiviral prophylaxis (yes) 0.187 (0.064-0.547) 0.002 0.193 (0.064-0.58) 0.003
HBsAg (+) 0.835 (0.177-3.932) 0.82
HBeAg (+) 0.527 (0.115-2.411) 0.409
HBV DNA (>2000 IU/ml) 0 0.996
Child Pugh score (B) 1.197 (0.254-5.636) 0.82
Tumor diameter (≥10cm) 5.312 (1.176-24.005) 0.03 5.132 (1.114-23.634) 0.036
Tumor number (multiple) 0.904 (0.244-3.345) 0.88
PVTT (≥2) 2.801 (0.357-21.984) 0.327
Extra−hepatic metastasis (yes) 0.987 (0.329-2.963) 0.981
AFP (≥400ng/ml) 3.026 (0.835-10.96) 0.092 2.379 (0.594-9.531) 0.221
ALT (≥50IU/L) 0.665 (0.222-1.987) 0.465
Albumin (≥35 g/L) 0.573 (0.152-2.163) 0.411
TBil (≥17.1μmol/L) 0.475 (0.166-1.357) 0.475
WBC (≥11*109/L) 1.663 (0.442-6.264) 0.452
Cycles of HAIC (≥4) 2.963 (0.818-10.734) 0.098 2.074 (0.523-8.217) 0.299

HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen; HBeAg, hepatitis B e antigen; DNA, deoxyribonucleic acid; PVTT, portal vein tumor thrombosis; AFP alpha−fetoprotein, ALT, alanine aminotransferase; TBil, total bilirubin; WBC, white blood cell; HAIC hepatic arterial infusion chemo−therapy.